Q&A: Comparator And Co-Therapy Drug Sourcing For Clinical Studies

In this Q&A with Rachel Curran, ‎Head of Sourcing Services and Special Accounts, Sharp Clinical, we discuss the requirements, challenges and solutions to comparator and co-therapy drug sourcing for clinical trials.

What is comparator and co-therapy (or co-medications) sourcing and what is its impact on clinical trials?

Comparator and co-therapy drugs are used in a clinical trial as a reference to compare the performance of the clinical drug candidate. Sourcing sufficient quantities of the appropriate comparator drugs in timely and cost-effective way can often be a challenge. Roughly two-thirds of clinical trials involve the use of comparators and co-therapies and it is a vital strategic operation as it can lead to delays and increased costs if managed poorly.